A new method of intralesional bleomycin therapy in the treatment of recalcitrant warts

Br J Dermatol. 1996 Dec;135(6):969-71. doi: 10.1046/j.1365-2133.1996.d01-1104.x.

Abstract

We have used a new technique of bleomycin injection to treat intractable palmar, plantar and periungual warts. Following local anaesthesia with topical EMLA (lignocaine and prilocaine) cream, 1 mg/ml bleomycin solution was dropped on to the wart and 'pricked' into the wart using a Monolet needle. We achieved 92% success rate which compares well with other authors whose success rates with intralesional bleomycin vary between 33 and 92%. We conclude that this technique of intralesional bleomycin therapy is an effective, safe and generally well tolerated treatment for recalcitrant warts.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antimetabolites, Antineoplastic / administration & dosage*
  • Antimetabolites, Antineoplastic / adverse effects
  • Antimetabolites, Antineoplastic / therapeutic use
  • Bleomycin / administration & dosage*
  • Bleomycin / adverse effects
  • Bleomycin / therapeutic use
  • Female
  • Foot Dermatoses / drug therapy*
  • Foot Dermatoses / pathology
  • Hand Dermatoses / drug therapy*
  • Hand Dermatoses / pathology
  • Humans
  • Injections, Intralesional
  • Male
  • Middle Aged
  • Raynaud Disease / chemically induced
  • Warts / drug therapy*
  • Warts / pathology

Substances

  • Antimetabolites, Antineoplastic
  • Bleomycin